Literature DB >> 12408231

Collagen XVIII: a novel heparan sulfate proteoglycan associated with vascular amyloid depositions and senile plaques in Alzheimer's disease brains.

Jack van Horssen1, Micha M M Wilhelmus, Ritva Heljasvaara, Taina Pihlajaniemi, Pieter Wesseling, Robert M W de Waal, Marcel M Verbeek.   

Abstract

Heparan sulfate proteoglycans (HSPGs) may play a role in the formation and persistence of senile plaques and neurofibrillary tangles in Alzheimer's disease brains. Recently, it has been demonstrated that the human extracellular matrix-associated molecule collagen XVIII is the first collagen carrying heparan sulfate side-chains. Two variants of collagen XVIII with both different signal peptides and N-terminal domains have been described and are referred to as the short and long form. To investigate the distribution of these variants we performed an immunohistochemical analysis by using specific well-characterized polyclonal antibodies. Anti-long huXVIII, a polyclonal antibody directed against the long variant of collagen XVIII, weakly stained large cortical and leptomeningeal vessels, whereas small cortical vessels remained unstained. Interestingly, all amyloid-laden vessels and classic senile plaques were strongly stained. Anti-all huXVIII, a polyclonal antibody directed against an epitope common to both collagen XVIII variants, intensely stained all types of cerebral blood vessels, cerebral amyloid angiopathy-affected vessels and classic senile plaques. Collagen XVIII expression was absent in neurofibrillary tangles. We conclude that collagen XVIII is a novel heparan sulfate proteoglycan associated with vascular A beta and classic senile plaques and that at least the long form of collagen XVIII accumulates in amyloid-laden vessels and classic senile plaques.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12408231     DOI: 10.1111/j.1750-3639.2002.tb00462.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  17 in total

Review 1.  Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution.

Authors:  Massimo Stefani; Christopher M Dobson
Journal:  J Mol Med (Berl)       Date:  2003-08-27       Impact factor: 4.599

2.  Endostatin binds nerve growth factor and thereby inhibits neurite outgrowth and neuronal migration in-vitro.

Authors:  Abraham Al Ahmad; Boyeon Lee; Jonathan Stack; Christi Parham; Joel Campbell; Douglas Clarke; Andrzej Fertala; Gregory J Bix
Journal:  Brain Res       Date:  2010-09-21       Impact factor: 3.252

Review 3.  The pathogenic implication of abnormal interaction between apolipoprotein E isoforms, amyloid-beta peptides, and sulfatides in Alzheimer's disease.

Authors:  Xianlin Han
Journal:  Mol Neurobiol       Date:  2010-01-07       Impact factor: 5.590

4.  Tenascin-C Is Associated with Cored Amyloid-β Plaques in Alzheimer Disease and Pathology Burdened Cognitively Normal Elderly.

Authors:  Zhiping Mi; Willi Halfter; Eric E Abrahamson; William E Klunk; Chester A Mathis; Elliott J Mufson; Milos D Ikonomovic
Journal:  J Neuropathol Exp Neurol       Date:  2016-07-21       Impact factor: 3.685

5.  Sulfatides facilitate apolipoprotein E-mediated amyloid-beta peptide clearance through an endocytotic pathway.

Authors:  Youchun Zeng; Xianlin Han
Journal:  J Neurochem       Date:  2008-05-13       Impact factor: 5.372

6.  Differences in extracellular matrix production and basic fibroblast growth factor response in skin fibroblasts from sporadic and familial Alzheimer's disease.

Authors:  Catia Bellucci; Cinzia Lilli; Tiziano Baroni; Lucilla Parnetti; Sandro Sorbi; Carla Emiliani; Eleonora Lumare; Paolo Calabresi; Stefania Balloni; Maria Bodo
Journal:  Mol Med       Date:  2007 Sep-Oct       Impact factor: 6.354

7.  Heparin accelerates gelsolin amyloidogenesis.

Authors:  Ji Young Suk; Fuming Zhang; William E Balch; Robert J Linhardt; Jeffery W Kelly
Journal:  Biochemistry       Date:  2006-02-21       Impact factor: 3.162

Review 8.  Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways.

Authors:  Steven M Greenberg; Brian J Bacskai; Mar Hernandez-Guillamon; Jeremy Pruzin; Reisa Sperling; Susanne J van Veluw
Journal:  Nat Rev Neurol       Date:  2019-12-11       Impact factor: 42.937

9.  Matrisome changes in Parkinson's disease.

Authors:  Margaret Downs; Manveen K Sethi; Rekha Raghunathan; Matthew D Layne; Joseph Zaia
Journal:  Anal Bioanal Chem       Date:  2022-02-02       Impact factor: 4.142

10.  The collagen chaperone HSP47 is a new interactor of APP that affects the levels of extracellular beta-amyloid peptides.

Authors:  Federico T Bianchi; Paola Camera; Ugo Ala; Daniele Imperiale; Antonio Migheli; Enrica Boda; Filippo Tempia; Gaia Berto; Ylenia Bosio; Salvatore Oddo; Frank M LaFerla; Stefano Taraglio; Carlos G Dotti; Ferdinando Di Cunto
Journal:  PLoS One       Date:  2011-07-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.